Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Child's Nervous System
Erschienen in: Child's Nervous System 8/2020

31.01.2020 | Focus Session

Prenatal genetic considerations in congenital ventriculomegaly and hydrocephalus

verfasst von: Adolfo Etchegaray, Sofia Juarez-Peñalva, Florencia Petracchi, Laura Igarzabal

Erschienen in: Child's Nervous System | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Fetal ventriculomegaly (VM) is a frequent finding in prenatal ultrasound. Rather than a proper diagnosis, VM is a sonographic sign, making prenatal counseling a complex and challenging undertaking. VM can range from severe pathologic processes leading to severe neurodevelopmental delay to normal variants.

Discussion

A growing number of genetic conditions with different pathophysiological mechanisms, inheritance patterns, and long-term prognosis have been associated both to isolated and complex fetal VM. These include chromosomal abnormalities, copy number variants, and several single gene diseases. In this review, we describe some of the most common genetic conditions associated with fetal VM and provide a simplified diagnostic workflow for the clinician.
Literatur
1.
Cardoza JD, Goldstein RB, Filly RA (1988) Exclusion of fetal ventriculomegaly with a single measurement: the width of the lateral ventricular atrium. Radiology 169:711–714
2.
Griffiths PD, Reeves MJ, Morris JE et al (2010) A prospective study of fetuses with isolated ventriculomegaly investigated by antenatal sonography and in utero MR imaging. Am J Neuroradiol 31:106–111
3.
Gaglioti P, Oberto M, Todros T (2009) The significance of fetal ventriculomegaly: etiology, short- and long-term outcomes. Prenat Diagn 29:381–388
4.
5.
Falip C, Blanc N, Maes E et al (2007) Postnatal clinical and imaging follow-up of infants with prenatal isolated mild ventriculomegaly: a series of 101 cases. Pediatr Radiol 37:981–989
6.
Griffiths PD, Brackley K, Bradburn M et al (2017) Anatomical subgroup analysis of the MERIDIAN cohort: ventriculomegaly. Ultrasound Obstet Gynecol 50:736–744
7.
Schrander-Stumpel C, Fryns JP (1998) Congenital hydrocephalus: nosology and guidelines for clinical approach and genetic counselling. Eur J Pediatr 157:355–362
8.
Rekate HL (2008) The definition and classification of hydrocephalus: a personal recommendation to stimulate debate. Cerebrospinal Fluid Res 5:2PubMedPubMedCentral
9.
International Society of Ultrasound in Obstetrics & Gynecology Education Committee (2007) Sonographic examination of the fetal central nervous system: guidelines for performing the “basic examination” and the “fetal neurosonogram.”. Ultrasound Obstet Gynecol 29:109–116
10.
Guibaud L (2009) Fetal cerebral ventricular measurement and ventriculomegaly: time for procedure standardization. Ultrasound Obstet Gynecol 34:127–130
11.
Nyberg DA, Luthy DA, Cheng EY et al (1995) Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 173:1030–1035
12.
Deren O, Mahoney MJ, Copel JA, Bahado-Singh RO (1998) Subtle ultrasonographic anomalies: do they improve the Down syndrome detection rate? Am J Obstet Gynecol 178:441–445
13.
Sohl BD, Scioscia AL, Budorick NE, Moore TR (1999) Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center. Am J Obstet Gynecol 181:898–903
14.
Wax JR, Guilbert J, Mather J et al (2000) Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus. J Ultrasound Med 19:689–694
15.
Aagaard-Tillery KM, Malone FD, Nyberg DA et al (2009) Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol 114:1189–1196PubMedPubMedCentral
16.
Duan H-L, Zhu X-Y, Zhu Y-J et al (2019) The application of chromosomal microarray analysis to the prenatal diagnosis of isolated mild ventriculomegaly. Taiwan J Obstet Gynecol 58:251–254
17.
Pagani G, Thilaganathan B, Prefumo F (2014) Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 44:254–260
18.
Melchiorre K, Bhide A, Gika AD et al (2009) Counseling in isolated mild fetal ventriculomegaly. Ultrasound Obstet Gynecol 34:212–224
19.
Zhao D, Cai A, Wang B et al (2018) Presence of chromosomal abnormalities in fetuses with isolated ventriculomegaly on prenatal ultrasound in China. Mol Genet Genomic Med 6:1015–1020PubMedPubMedCentral
20.
D’Addario V, Rossi AC (2012) Neuroimaging of ventriculomegaly in the fetal period. Semin Fetal Neonatal Med 17:310–318
21.
Pilu G, Falco P, Gabrielli S et al (1999) The clinical significance of fetal isolated cerebral borderline ventriculomegaly: report of 31 cases and review of the literature. Ultrasound Obstet Gynecol 14:320–326
22.
Iwamoto H, Muroi A, Sekine T et al (2019) Unusual form of obstructive hydrocephalus in association with 6q terminal deletion syndrome: a case report and literature review. Pediatr Neurosurg 54:419–423
23.
Bromley B, Frigoletto FD, Benacerraf BR (1991) Mild fetal lateral cerebral ventriculomegaly: clinical course and outcome. Am J Obstet Gynecol 164:863–867
24.
Graham E, Duhl A, Ural S et al (2001) The degree of antenatal ventriculomegaly is related to pediatric neurological morbidity. J Matern Fetal Neonatal Med 10:258–263
25.
Hannon T, Tennant PWG, Rankin J, Robson SC (2012) Epidemiology, natural history, progression, and postnatal outcome of severe fetal ventriculomegaly. Obstet Gynecol 120:1345–1353
26.
Devaseelan P, Cardwell C, Bell B, Ong S (2010) Prognosis of isolated mild to moderate fetal cerebral ventriculomegaly: a systematic review. J Perinat Med 38:401–409
27.
Sethna F, Tennant PWG, Rankin JC, Robson S (2011) Prevalence, natural history, and clinical outcome of mild to moderate ventriculomegaly. Obstet Gynecol 117:867–876
28.
Nicolaides KH, Berry S, Snijders RJ et al (1990) Fetal lateral cerebral ventriculomegaly: associated malformations and chromosomal defects. Fetal Diagn Ther 5:5–14
29.
Gezer C, Ekin A, Ozeren M et al (2014) Chromosome abnormality incidence in fetuses with cerebral ventriculomegaly. J Obstet Gynaecol 34:387–391
30.
Wang Y, Cao L, Liang D et al (2018) Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study. Am J Obstet Gynecol 218:244.e1–244.e17
31.
Wang Y, Hu P, Xu Z (2018) Copy number variations and fetal ventriculomegaly. Curr Opin Obstet Gynecol 30:104–110
32.
Van den Hof MC, Wilson RD, Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada, Genetics Committee, Society of Obstetricians and Gynaecologists of Canada (2005) Fetal soft markers in obstetric ultrasound. J Obstet Gynaecol Can 27:592–636
33.
Agathokleous M, Chaveeva P, Poon LCY et al (2013) Meta-analysis of second-trimester markers for trisomy 21. Ultrasound Obstet Gynecol 41:247–261
34.
American College of Obstetricians and Gynecologists Committee on Genetics (2013) Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 122:1374–1377
35.
Society for Maternal-Fetal Medicine (SMFM), Dugoff L, Norton ME, Kuller JA (2016) The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol 215:B2–B9
36.
Duncan A, Langlois S, Douglas Wilson R et al (2011) Use of array genomic hybridization technology in prenatal diagnosis in Canada. J Obstet Gynaecol Can 33:1256–1259
37.
Hillman S, McMullan DJ, Maher ER, Kilby MD (2013) The use of chromosomal microarray in prenatal diagnosis. Obstet Gynaecol 15:80–84
38.
Hu P, Wang Y, Sun R, et al (2017) Copy number variations with isolated fetal ventriculomegaly. Curr Mol Med 17
39.
Shaffer LG, Rosenfeld JA, Dabell MP et al (2012) Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn 32:986–995PubMedPubMedCentral
40.
Donnelly JC, Platt LD, Rebarber A et al (2014) Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 124:83–90PubMedPubMedCentral
41.
Zhang Y, Huang L, Huang X et al (2018) Chromosomal aberrations and CNVs in twin fetuses with cardiovascular anomalies: comparison between monochorionic diamniotic and dichorionic diamniotic twins. Prenat Diagn 38:318–327
42.
Martin CL, Kirkpatrick BE, Ledbetter DH (2015) Copy number variants, aneuploidies, and human disease. Clin Perinatol 42(227–42):vii
43.
Fox NS, Monteagudo A, Kuller JA et al (2018) Mild fetal ventriculomegaly: diagnosis, evaluation, and management. Am J Obstet Gynecol 219:B2–B9
44.
Shaheen R, Sebai MA, Patel N et al (2017) The genetic landscape of familial congenital hydrocephalus. Ann Neurol 81:890–897
45.
Bickers DS, Adams RD (1949) Hereditary stenosis of the aqueduct of SYLVIUS as a cause of congenital hydrocephalus. Brain 72:246–262
46.
Sun Y, Li Y, Chen M, et al (2019) A novel silent mutation in the L1CAM gene causing fetal hydrocephalus detected by whole-exome sequencing. Front Genet 10
47.
Tully HM, Dobyns WB (2014) Infantile hydrocephalus: a review of epidemiology, classification and causes. Eur J Med Genet 57:359–368PubMedPubMedCentral
48.
Chow CW, Halliday JL, McD Anderson R et al (1985) Congenital absence of pyramids and its significance in genetic diseases. Acta Neuropathol 65:313–317
49.
Vos YJ, de Walle HEK, Bos KK et al (2010) Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis. J Med Genet 47:169–175
50.
Schrander-Stumpel C, Höweler C, Jones M et al (1995) Spectrum of X-linked hydrocephalus (HSAS), MASA syndrome, and complicated spastic paraplegia (SPG1): clinical review with six additional families. Am J Med Genet 57:107–116
51.
Huo L, Teng Z, Wang H, Liu X (2019) A novel splice site mutation in AP 1S2 gene for X-linked mental retardation in a Chinese pedigree and literature review. Brain Behav 9:e01221PubMedPubMedCentral
52.
Ruggeri G, Timms AE, Cheng C et al (2018) Bi-allelic mutations of CCDC88C are a rare cause of severe congenital hydrocephalus. Am J Med Genet A 176:676–681PubMedPubMedCentral
53.
Kousi M, Katsanis N (2016) The genetic basis of hydrocephalus. Annu Rev Neurosci 39:409–435
54.
55.
56.
Ali MM, Chasen ST, Norton ME (2017) Testing for Noonan syndrome after increased nuchal translucency. Prenat Diagn 37:750–753
57.
Bakker M, Pajkrt E, Mathijssen IB, Bilardo CM (2011) Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 31:833–840
58.
Gaudineau A, Doray B, Schaefer E et al (2013) Postnatal phenotype according to prenatal ultrasound features of Noonan syndrome: a retrospective study of 28 cases. Prenat Diagn 33:238–241
59.
de Mooij YM, de Mooij YM, van den Akker NMS et al (2011) Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome. Prenat Diagn 31:159–166
60.
Baldassarre G, Mussa A, Dotta A et al (2011) Prenatal features of Noonan syndrome: prevalence and prognostic value. Prenat Diagn 31:949–954
61.
Houweling AC, de Mooij YM, van der Burgt I, et al (2010) Prenatal detection of Noonan syndrome by mutation analysis of the PTPN11 and the KRASgenes. Prenat Diagn
62.
Allanson JE (2007) Noonan syndrome. Am J Med Genet C: Semin Med Genet 145C:274–279
63.
Godfrey C, Clement E, Mein R et al (2007) Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130:2725–2735
64.
Dobyns WB, Pagon RA, Armstrong D et al (1989) Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 32:195–210
65.
Falsaperla R, Praticò AD, Ruggieri M, et al (2016) Congenital muscular dystrophy: from muscle to brain. Ital J Pediatr 42
66.
Low ASC, Lee SL, Tan ASA et al (2005) Difficulties with prenatal diagnosis of the walker-Warburg syndrome. Acta Radiol 46:645–651
67.
Lacalm A, Nadaud B, Massoud M et al (2016) Prenatal diagnosis of cobblestone lissencephaly associated with Walker-Warburg syndrome based on a specific sonographic pattern. Ultrasound Obstet Gynecol 47:117–122
68.
Schwartz RS (2011) Ciliopathies. N Engl J Med 364:1533–1543
69.
70.
Badano JL, Mitsuma N, Beales PL, Katsanis N (2006) The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 7:125–148
71.
Putoux A, Thomas S, Coene KLM et al (2011) KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes. Nat Genet 43:601–606PubMedPubMedCentral
72.
Sotak BN, Gleeson JG (2012) Can’t get there from here: cilia and hydrocephalus. Nat Med 18:1742–1743
73.
Barisic I, Boban L, Loane M et al (2015) Meckel–Gruber syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in Europe. Eur J Hum Genet 23:746–752
74.
Hartill V, Szymanska K, Sharif SM, et al (2017) Meckel–Gruber syndrome: an update on diagnosis, clinical management, and research advances. Front Pediatr 5
75.
Khurana S, Saini V, Wadhwa V, Kaur H (2017) Meckel–Gruber syndrome: ultrasonographic and fetal autopsy correlation. J Ultrasound 20:167–170PubMedPubMedCentral
76.
Knopp C, Rudnik-Schöneborn S, Eggermann T et al (2015) Syndromic ciliopathies: from single gene to multi gene analysis by SNP arrays and next generation sequencing. Mol Cell Probes 29:299–307
77.
Chen C-P (2007) Meckel syndrome: genetics, perinatal findings, and differential diagnosis. Taiwan J Obstet Gynecol 46:9–14
78.
Saraiva JM, Baraitser M (1992) Joubert syndrome: a review. Am J Med Genet 43:726–731
79.
Parisi MA (2009) Clinical and molecular features of Joubert syndrome and related disorders. Am J Med Genet C: Semin Med Genet 151C:326–340
80.
81.
Zhu L, Xie L (2017) Prenatal diagnosis of Joubert syndrome: a case report and literature review. Medicine 96:e8626PubMedPubMedCentral
82.
Shen O, Ben-Sira L, Rosenak D, Michaelson-Cohen R (2014) Early second-trimester molar tooth sign. Fetal Diagn Ther 36:259–262
83.
Haratz KK, Shulevitz SL, Leibovitz Z et al (2019) Fourth ventricle index: sonographic marker for severe fetal vermian dysgenesis/agenesis. Ultrasound Obstet Gynecol 53:390–395
84.
Quarello E, Molho M, Garel C et al (2014) Prenatal abnormal features of the fourth ventricle in Joubert syndrome and related disorders. Ultrasound Obstet Gynecol 43:227–232
85.
Bachmann-Gagescu R, Dempsey JC, Phelps IG et al (2015) Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneity. J Med Genet 52:514–522
86.
Dempsey JC, Phelps IG, Bachmann-Gagescu R et al (2017) Mortality in Joubert syndrome. Am J Med Genet A 173:1237–1242
87.
88.
Wei Q, Zhang Y, Schouteden C et al (2016) The hydrolethalus syndrome protein HYLS-1 regulates formation of the ciliary gate. Nat Commun 7:12437PubMedPubMedCentral
89.
Ferrante MI, Feather SA, Bulfone A et al (2001) Identification of the gene for oral-facial-digital type I syndrome. Am J Hum Genet 68:569–576PubMedPubMedCentral
90.
Feather SA, Winyard PJ, Dodd S, Woolf AS (1997) Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred. Nephrol Dial Transplant 12:1354–1361
91.
Bruel A-L, Franco B, Duffourd Y et al (2017) Fifteen years of research on oral–facial–digital syndromes: from 1 to 16 causal genes. J Med Genet 54:371–380PubMedPubMedCentral
92.
Bouman A, Alders M, Oostra RJ et al (2017) Oral-facial-digital syndrome type 1 in males: congenital heart defects are included in its phenotypic spectrum. Am J Med Genet A 173:1383–1389PubMedPubMedCentral
93.
Alby C, Boutaud L, Bonnière M et al (2018) In utero ultrasound diagnosis of corpus callosum agenesis leading to the identification of orofaciodigital type 1 syndrome in female fetuses. Birth Defects Res 110:382–389
94.
Drury S, Williams H, Trump N et al (2015) Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn 35:1010–1017
95.
Thauvin-Robinet C, Rousseau T, Durand C et al (2001) Familial orofaciodigital syndrome type I revealed by ultrasound prenatal diagnosis of porencephaly. Prenat Diagn 21:466–470
96.
Hogan GR, Bauman ML (1971) Hydrocephalus in Apert’s syndrome. J Pediatr 79:782–787
97.
Murovic JA, Posnick JC, Drake JM et al (1993) Hydrocephalus in Apert syndrome: a retrospective review. Pediatr Neurosurg 19:151–155
98.
Fukumitsu H, Ohmiya M, Nitta A et al (2000) Aberrant expression of neurotrophic factors in the ventricular progenitor cells of infant congenitally hydrocephalic rats. Childs Nerv Syst 16:516–521
99.
Tan AP, Mankad K (2018) Apert syndrome: magnetic resonance imaging (MRI) of associated intracranial anomalies. Childs Nerv Syst 34:205–216
100.
Collmann H, Sörensen N, Krauss J (2005) Hydrocephalus in craniosynostosis: a review. Childs Nerv Syst 21:902–912
101.
Hassed S, Shewmake K, Teo C et al (1997) Shprintzen-Goldberg syndrome with osteopenia and progressive hydrocephalus. Am J Med Genet 70:450–453
102.
Pierre-Kahn A, Hirsch JF, Renter D et al (1980) Hydrocephalus and achondroplasia. Pediatr Neurosurg 7:205–219
103.
Swift D, Nagy L, Robertson B (2012) Endoscopic third ventriculostomy in hydrocephalus associated with achondroplasia. J Neurosurg Pediatr 9:73–81
104.
Steinbok P, Hall J, Flodmark O (1991) Hydrocephalus in achondroplasia: the possible role of intracranial venous hypertension. Ann Rev Hydrocephalus:104–104
105.
McKechnie L, Vasudevan C, Levene M (2012) Neonatal outcome of congenital ventriculomegaly. Semin Fetal Neonatal Med 17:301–307
106.
Laskin MD, Kingdom J, Toi A et al (2005) Perinatal and neurodevelopmental outcome with isolated fetal ventriculomegaly: a systematic review. J Matern Fetal Neonatal Med 18:289–298
107.
Wyldes M (2004) Isolated mild fetal ventriculomegaly. Arch Dis Child Fetal Neonatal Ed 89:9F–13F
108.
Pisapia JM, Sinha S, Zarnow DM et al (2017) Fetal ventriculomegaly: diagnosis, treatment, and future directions. Childs Nerv Syst 33:1113–1123
109.
Breeze ACG, Alexander PMA, Murdoch EM et al (2007) Obstetric and neonatal outcomes in severe fetal ventriculomegaly. Prenat Diagn 27:124–129
110.
Carta S, Kaelin Agten A, Belcaro C, Bhide A (2018) Outcome of fetuses with prenatal diagnosis of isolated severe bilateral ventriculomegaly: systematic review and meta-analysis. Ultrasound Obstet Gynecol 52:165–173
Metadaten
Titel
Prenatal genetic considerations in congenital ventriculomegaly and hydrocephalus
verfasst von
Adolfo Etchegaray
Sofia Juarez-Peñalva
Florencia Petracchi
Laura Igarzabal
Publikationsdatum
31.01.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 8/2020
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-020-04526-5

Weitere Artikel der Ausgabe 8/2020

Child's Nervous System 8/2020 Zur Ausgabe

Original Article

OssDsign cranioplasty in children: a single-centre experience

Review Article

Surgical management of Chiari malformation type II

Original Article

Intracranial abscesses in children at Ile-Ife, Nigeria: a case series and review of literature

Invited Paper

Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review

Letter to the Editor

Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19

Focus Session

Fetal brain damage in congenital hydrocephalus

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.